A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where communities with thousands of participants share “before and after” photos, administration instructions and assertions of next-day British shipping. Sellers market the drug there before directing customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in individuals administering substances of unknown origin.
Some professionals said the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.
Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer laws, risking penalties, prosecution or prison.
Service Reaction and Material Removal
According to the social media company, the platform has taken down violative content and prohibited associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures.
Online Marketplace Operations
Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of slimming results, glowing reviews and step-by-step instructions for mixing or administering at home.
After minutes of entering one group, a seller posted WhatsApp details, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Item Information and Pricing
Inside these groups, posts display black plastic packages with postal service stickers, stating to include new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at 160 pounds for 20mg. When asked how long a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram said it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Medical Professional Warnings
“People are administering materials they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental product not yet approved … may subject patients to potentially significant health risks”.
